Related Experiment Video
Updated: Nov 10, 2025
08:27
Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
11.2K
Lysophospholipids in Lung Inflammatory Diseases
1Department of Physiology and Cell Biology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Advances in Experimental Medicine and Biology
|March 31, 2021
Summary
Lysophospholipids like lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are key in lung inflammation. Their signaling via G protein-coupled receptors (GPCRs) is crucial for diseases like asthma and COPD.
Area of Science:
- Lipid biochemistry
- Pulmonary medicine
- Cell signaling
Background:
- Lysophospholipids (LPLs) are bioactive lipids derived from phospholipids, playing critical roles in physiological and pathological processes.
- Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are simple LPLs implicated in lung inflammatory diseases.
- G protein-coupled receptors (GPCRs) are the primary mediators of LPA and S1P signaling pathways.
Purpose of the Study:
- To elucidate the role of LPA and S1P in lung inflammatory conditions.
- To explore the involvement of LPL metabolizing enzymes and receptor modulators.
- To detail GPCR-mediated signaling in the context of specific lung diseases.
Main Methods:
- Review of existing literature on LPLs, GPCRs, and lung inflammation.
- Analysis of signaling pathways involving LPA and S1P.
- Focus on pathobiology of acute respiratory distress syndrome, asthma, and COPD.
Main Results:
- LPA and S1P signaling through GPCRs significantly contribute to lung inflammation.
- Specific enzymes and receptor targets are identified as critical in LPL-mediated lung pathology.
- Understanding these pathways offers insights into disease mechanisms.
Conclusions:
- LPA and S1P are critical players in the pathogenesis of lung inflammatory diseases.
- Targeting LPL-GPCR pathways presents potential therapeutic strategies for respiratory conditions.
- Further research into LPL signaling is essential for developing novel treatments for asthma, COPD, and ARDS.
Keywords:
G protein–coupled receptorsLung inflammationLysophosphatidic acidLysophospholipidsSignaling pathwaySphingosine-1-phosphateMore Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.5K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
792
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
792
01:20COPD: Pathogenesis and Clinical Features
1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
01:29Pneumonia II: Pathophysiology
1.5K
The pathophysiology of pneumonia involves the following steps:
1.5K
01:26Asthma-II: Pathophysiology and Classification
3.5K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K